Is Merck & Co., Inc. (MRK) the Most Undervalued High Quality Stock to Buy According to Analysts?
We recently published a list of 10 Most Undervalued High Quality Stocks to Buy According to Analysts. In this article, we are ...
Merck & Co., Inc. (MRK) Among The Best Cheap Dividend Stock To Buy Right Now
We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are going to take a look ...
New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle
The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.
Fierce Pharma3d
In patent clash over injectable Keytruda, Merck and Halozyme dig in for a fight
Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...
Merck & Co.'s Real Value: A Deep Dive Into Its Fundamentals
While Merck reported strong financial results in recent quarters, it faces both upsides and risks in the future. Read why I'm ...
ROSEN, A TOP RANKED LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and ...
The Reporter2d
Merck seeks to trade wetlands for potential to add parking or building
What we want to do is remove about 0.35 acres of current site wetlands, in exchange for wetlands that are already in place, ...
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
NEW YORK CITY, NY / ACCESS Newswire / March 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Delaware approves $30.2 million taxpayer-funded grant for Merck to build in state
The state of Delaware has offered Merck a $30.2 million grant to encourage the company to choose the Wilmington-area location. If Merck accepts the grant, the company would be required to create 375 ...
Merck expects cancer therapy Keytruda to be part of government price setting in 2026
Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...
GlobalData on MSN2d
Merck’s lupus drug fails in SLE cohort of Phase II trial
Merck’s oral TLR7/8 inhibitor enpatoran has failed to meet the primary endpoint in a subgroup of patients, but development of ...
Merck (MRK) Ascends While Market Falls: Some Facts to Note
Merck (MRK) ended the recent trading session at $94, demonstrating a +0.87% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily loss of 1.78%. Meanwhile, ...